CASE REPORT
Tuberculosis in a patient with rheumatoid arthritis treated with infliximab
More details
Hide details
Online publication date: 2012-11-06
Reumatologia 2012;50(5):444-448
KEYWORDS
ABSTRACT
Tumor necrosis factor α (TNF-α) plays a significant role in formation and stabilization of tuberculous granulomatous structures. That is why starting treatment with a TNF-α inhibitor increases tuberculosis morbidity. In developed countries it is usually a result of reactivation of latent infection. Hence proper diagnostics of latent tuberculosis infection, and starting chemoprophylaxis if necessary, is a standard procedure.
We report a case of a 60-year-old patient with rheumatoid arthritis who revealed pleurisy and pericarditis after treatment with infliximab (Fig. 1). After starting anti-tuberculosis therapy the patient’s condition improved and changes in X-ray images disappeared.
Rheumatoid arthritis was treated with leflunomide for one year, then thoracic X-ray was performed and revealed changes described as fibro-cavernous tuberculosis (Fig. 2). Despite negative bacteriological test results, anti-tuberculosis treatment was repeated.
The article presents the advantages and disadvantages of skin tuberculin test and IGRA tests (interferon- release assay), highlighting the important role of the IGRA test in diagnostics of latent tuberculosis infections.
The paper proposes differential diagnostics which need to be carried out in case of the described clinical and radiological picture.
REFERENCES (7)
1.
Adamski Z, Linke K, Samborski W. Leczenie biologiczne w dermatologii, gastroenterologii i reumatologii. Termedia, Poznań 2010; 298-300.
2.
Korzeniewska-Koseła M. Zapobieganie gruźlicy u chorych leczonych antagonistami czynnika martwicy nowotworów. Reumatologia 2010; 48: 4-13.
3.
Kucharz EJ, Korzeniewska-Koseła M, Kotulska A. Zalecenia postępowania i leczenia gruźlicy u chorych leczonych antagonistami TNF-α. Reumatologia 2008; 46: 51-54.
4.
Furst DE, Cush J, Kaufmann S, et al. Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents. Ann Rheum Dis 2002; 61 Suppl 2: 62-63.
5.
Antczak A. Wielka interna. T. 1. Pulmonologia, część I. Medical Tribune Polska, Warszawa 2011; 268, 271-272.
6.
Januszewicz W, Kokot F. Interna. T. I. Wydawnictwo Lekarskie PZWL, Warszawa 2004; 376-377.
7.
British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-αlpha treatment. Thorax 2005; 60: 800-805.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.